A Focus On Improving The Clinical Trials Environment

A new umbrella association for clinical research in Switzerland has been set up to provide an optimal environment for conducting clinical trials in the Western European country. BMI welcomes this development as it reinforces our view that the country's medicine authorities have recognised the importance of such developments in promoting the country as an important site for clinical trials and research.

To read the full article, please choose one of the following options: